GSK’s Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency
Source: GSK
Over 25 million people in Europe have received GSK’s shingles vaccine since 2018.
If approved, the new presentation will offer a convenient administration option to healthcare professionals
Globally, up to 1 in 3 adults will develop shingles in their lifetime 1,2,3,4
Over 25 million people in Europe have received GSK’s shingles va… [3716 chars]